In recent years, cerebral pericytes have become the focus of extensive research in vascular biology and pathology. The importance of pericytes in blood brain barrier formation and physiology is now demonstrated but its molecular basis remains largely unknown. As the pathophysiological role of cerebral pericytes in neurological disorders is intriguing and of great importance, the in vitro models are not only sufficiently appropriate but also able to incorporate different techniques for these studies. Several methods have been proposed as in vitro models for the extraction of cerebral pericytes, although an antibiotic-free protocol with high output is desirable. Most importantly, a method that has increased output per extraction reduces the usage of more animals.
Introduction
Cerebral pericytes are an essential component of the neurovascular unit (NVU), which comprises a functional unit with the cerebral endothelial cells of the blood brain barrier (BBB), glial cells, extracellular matrix and neurons. Pericytes are a vital part in regulated functioning of the central nervous system (CNS) as they serve as one of the interfaces for the exchange of molecular and cellular information.
Cerebral pericytes are embedded in the abluminal side of the brain microvessels, and are essential for establishing 1 and maintaining 2 the BBB physiology. Several recent works have also highlighted the role of cerebral pericytes in angiogenesis 3 and vessel maturation 4 , endothelial morphogenesis 5 and survival 6 , and in controlling the brain cholesterol metabolism 7 . Importantly, the dysregulation in any of these processes are etiological hallmarks of neurodegenerative diseases.
Indeed, pericytes are a functional necessity for normal BBB functioning and its protection against the progression of several neurological diseases. Degenerating physiology and loss of pericytes are common denominators in the progression of Alzheimer's disease 8 , neuronal loss during white matter dysfunction 9 , multiple sclerosis 10 , septic encephalopathy 11 , acute phase ischemic stroke 12 and in other neurological disorders. Pericytes are also instrumental in tumor metastasis 13 . Interestingly, pericytes have also been shown to exhibit a rescuing role after neurological trauma and disorders: in remyelination in brain 1 , ischemic stroke, spinal cord injury 14 and promoting angiogenesis 15 . The susceptibility of pericytes to reinforce the pathophysiological manifestation of neurological trauma and disorders makes them a potential therapeutic target 16 .
In vitro research models of pericytes in the BBB are important tools to conduct extensive studies. These models provide a platform for more elaborate studies by representing working models of the BBB and more. For instance, these models can be used to understand the cellular physiology within pericytes and among other cell types of the NVU. Also, in vitro models are firsthand investigation tools for testing the pharmacological influence of new drugs and molecules on pericytes. These models can also be used to understand the pathophysiological role of pericytes in relation to neurological disorders. Nevertheless, the development of in vitro models requires increased output to enable experimental freedom. These models should be easy and quick, and reduce the number of experimental animals used. In addition, the ability to develop such models into a double and triple cell culture models is desirable.
There are many protocols that have been developed. The protocols proposed by Tigges et al. 17 , Chen et al. 18 , Thomsen et al. 19 , Yamazaki et al. 20 min at 37 °C. Following one-step separation (centrifugation in 22% BSA) of the cells, the myelin layer is removed and the pellet is washed twice in ECGM. The microvessels are plated in 3 wells of a collagen I coated 6-well plates. After reaching confluence, the cells are passaged twice and later maintained in PGM. In the end, if cells are passed in ratio of 3, we can obtain 27 wells of 6-well plates only at the use of 10 mice in the beginning of the protocol.
In Thomsen et al., the authors suggest isolation of cerebral pericytes via a two-step enzyme digestion 19 . Meninges and white matter are removed, and brain samples are cut into small pieces. The tissue pieces undergo the first enzyme reaction in collagenase/DNase I for 75 min at 37 °C, following one step of separation in 20% BSA. The pellet is collected and further digested in collagenase/dispase/DNase I for 50 min at 37 °C. This step is followed by microvessel separation in a 33% Percoll gradient and further washed once. The microvessels are seeded on collagen IV/fibronectin coated 35 mm dishes. The proliferation of pericytes is favored by 10% FCS and gentamicin sulphate in DMEM for 10 days. In another two-step enzyme digestion approach, Yamazaki et al. suggest mincing of the excised tissue in cold DMEM 20 . In the first enzyme reaction, samples are treated with collagenase/DNase I for 75 min at 37 °C. Following one step centrifugation, the pellet is again washed once and a second enzyme reaction is initiated in collagenase/dispase for 60 min at 37 °C. Following a one-step separation, the pellet is resuspended and centrifuged in 22% BSA solution. Finally, the microvascular pellet is resuspended and plated in a 6-well plate. For 5 mouse brains, 1 well of a 6-well plate can be plated. To obtain the pericytes, endothelial cultures are passaged thrice while maintained in mouse brain endothelial cell (mBEC) medium II. Crouch and Doetsch 20 suggest pericyte purification method by FACS. Tissue samples from cortex and ventricularsubventricular zone of mouse brain are micro-dissected and minced thoroughly with a scalpel. After collagenase/dispase enzyme incubation for 30 min at 37 °C, the digested tissue is separated from myelin and debris centrifuged in a 22% v/v Percoll solution. The cell suspension is then incubated in fluorescently conjugated antibodies for FACS analysis and sorting. The sorted cells are plated in collagen coated wells of 24 well plate. It is suggested that one cortex yields enough cells for one plating in 1 well of 24-well plate.
Even if productive, these methods come with several limitations, from the usage of high number of animals for single batch isolation to a very limited amount of output.
During the development of this proposed protocol, we were successful in obtaining high output: 9 wells of a 6-well plate from as few as 10 mice. To this end, removal of meninges ensures the one step removal of large vessels from the tissue. The Dounce tissue grinder is more appropriate for soft tissues such as the brain. It also ensures sample reduction with the loose pestle, homogenization with the tight pestle, and prevents unnecessary cellular damage. One of the main objectives in primary cell culture protocols is the minimal waste of tissue and extended retrieval of cerebral vasculature. In the presented protocol, this is achieved by repetitive centrifugation of the dextran-BSA infused tissue homogenate. A three-step centrifugation approach helps to recover large quantities of vasculature from the tissue homogenate. This provides a 3x enhanced recovery of microvessels. Following separation, filtration is the next essential step, which favors the exclusion of smooth muscle cell associated large vessels. As mentioned before a combination of different enzymes has been proposed for enzymatic digestion. While DNase and collagenase/dispase are used to reduce clumps of cells and isolate single cells respectively, it is very important to prevent cell death in such an invasive environment and this is prevented by TLCK, which thereby increases the final yield. Initially, the first passage is allowed to grow an endothelial monolayer, which later supports the growth of attached pericytes on the unilayer. Since the survival of primary endothelial cells is reduced upon passaging, it enhances the probability for pericyte retrieval. Moreover, this protocol employs another passaging that ensures avoidance of endothelial cell contamination. It should be noted that with a higher number of cells from P2, the dependency on further passaging of the cells is reduced. In addition, it reduces the possibility of pericyte growth being overtaken by smooth muscle cells, which proliferate on much higher rate.
In order to achieve a higher output, there are several steps that are critical and should be accurately performed with respect to temperature and time. The mixing of tissue homogenate into BSA-dextran should be fast. The pellet dissociation after the centrifugation steps should be quick to prevent cell death. Moreover, 33 min of enzymatic digestion should be done with precision and care. One of the limitations for this protocol is the 7-8 day duration that endothelial unilayer is allowed to grow and further facilitate the growth of pericytes. Evidently, the isolation of microvessels is btter, the growth of unilayer is faster, and hence there are an increased number of pericytes. It is recommended not to use less than 10 mice in each extraction to ensure an adequate number of microvascular fractions to support the pericyte growth further. If the aforementioned points are followed carefully, the desired cell density for cerebral pericyte culture can be easily achieved.
In vitro models provide a feasible platform for the development of derivative models to obtain more information on the pathophysiological relevance and communication among the other cells of the NVU during neurological disorders. Isolated pericytes can be incorporated in a bicellular culture (with endothelial or glial cells) and tri-cellular culture (endothelial and glial cells) models. The development of these models has not been discussed here. To conclude, this protocol provides one approach for the isolation of primary cells with higher output and a better platform for in vitro research related to the cerebral pericyte biology.
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